[The progress of Alzheimer's disease research biomarkers--sensitivity and specificity].
Rapid growth of dementia patients prompts improvement of medical and care systems. For this reason, biological markers for Alzheimer's disease are necessary, which enable us detect Alzheimer's disease before onset of dementia and evaluate drug effects on evidence based procedure. Here, we summarized the developing field of biological markers and reported recent results of large-scale multicenter study of CSF tau and A beta for clinical practice.